IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.

Item Statistics

Results from the first multicenter, open-label, phase IIIb study investigating the combination of pertuzumab with subcutaneous trastuzumab and a taxane in patients with HER2-positive metastatic breast cancer (SAPPHIRE)

RepositoryUniversity of Queensland [UQ eSpace]
URL
Author(s)Woodward, Natasha; De Boer, Richard H.; Redfern, Andrew; White, Michelle; Young, Jennifer; Truman, Matt; Beith, Jane
Item TypeArticle
DOIhttps://doi.org/10.1016/j.clbc.2019.02.008

Usage Date Range

     

Reporting Period Total Dec-2019 Jan-2020 Feb-2020 Mar-2020 Apr-2020 May-2020 Jun-2020 Jul-2020 Aug-2020 Sep-2020 Oct-2020 Nov-2020 Dec-2020 Jan-2021 Feb-2021 Mar-2021 Apr-2021 May-2021 Jun-2021 Jul-2021 Aug-2021 Sep-2021 Oct-2021 Nov-2021 Dec-2021
165 2 6 4 4 8 6 5 8 7 11 12 1 2 9 4 4 0 6 7 8 9 12 16 11 3

Average downloads per month for selected period: 6.6

Jisc logo Cranfield logo CAVAL logo